Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (431-440 of 666) with videos related to

Pageof 67
Sort By:
Circulation|September 1, 1975
The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosisA Kaegi, G F Pineo, A Shimizu, et al.
Neurology|February 5, 1999
Bilateral optic neuropathy with IgGkappa multiple myeloma improved after myeloablative chemotherapyF S Lieberman, J Odel, J Hirsh, et al.
Chest|September 3, 1998
The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Chest|October 1, 1992
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effectsJ Hirsh, J E Dalen, V Fuster, et al.
Pharmacological Reviews|March 1, 1994
Low molecular weight heparin: a critical analysis of clinical trialsD Green, J Hirsh, J Heit, et al.
Thrombosis and Haemostasis|November 24, 1989
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacementM N Levine, A Planes, J Hirsh, et al.
Thrombosis Research|November 15, 1982
Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasmaF A Ofosu, G Modi, A L Cerskus, et al.
Archives of Internal Medicine|May 7, 1998
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Thrombosis Research|August 1, 1981
Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparinF A Ofosu, M A Blajchman, G Modi, et al.
Thrombosis Research|January 1, 1979
Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation in vivo and its prevention by heparinM R Buchanan, E Dejana, J P Cazenave, et al.
Pageof 67

Showing results (431-440 of 666) with videos related to

Sort By:
Pageof 67
Circulation|September 1, 1975
The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosisA Kaegi, G F Pineo, A Shimizu, et al.
Neurology|February 5, 1999
Bilateral optic neuropathy with IgGkappa multiple myeloma improved after myeloablative chemotherapyF S Lieberman, J Odel, J Hirsh, et al.
Chest|September 3, 1998
The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Chest|October 1, 1992
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effectsJ Hirsh, J E Dalen, V Fuster, et al.
Pharmacological Reviews|March 1, 1994
Low molecular weight heparin: a critical analysis of clinical trialsD Green, J Hirsh, J Heit, et al.
Thrombosis and Haemostasis|November 24, 1989
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacementM N Levine, A Planes, J Hirsh, et al.
Thrombosis Research|November 15, 1982
Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasmaF A Ofosu, G Modi, A L Cerskus, et al.
Archives of Internal Medicine|May 7, 1998
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Thrombosis Research|August 1, 1981
Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparinF A Ofosu, M A Blajchman, G Modi, et al.
Thrombosis Research|January 1, 1979
Uncontrolled PGI2 production by whole vessel wall segments due to thrombin generation in vivo and its prevention by heparinM R Buchanan, E Dejana, J P Cazenave, et al.
Pageof 67